1. Home
  2. MITK vs ALLO Comparison

MITK vs ALLO Comparison

Compare MITK & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mitek Systems Inc.

MITK

Mitek Systems Inc.

HOLD

Current Price

$17.25

Market Cap

723.9M

Sector

Technology

ML Signal

HOLD

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$2.06

Market Cap

707.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MITK
ALLO
Founded
1983
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
723.9M
707.6M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
MITK
ALLO
Price
$17.25
$2.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
15
Target Price
$15.00
$8.35
AVG Volume (30 Days)
993.9K
8.0M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
171.43
34.09
EPS
0.25
N/A
Revenue
$45,390,000.00
N/A
Revenue This Year
$9.55
N/A
Revenue Next Year
$8.07
$142,416.42
P/E Ratio
$69.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.53
$0.99
52 Week High
$17.97
$4.46

Technical Indicators

Market Signals
Indicator
MITK
ALLO
Relative Strength Index (RSI) 60.75 51.40
Support Level $13.15 $1.85
Resistance Level $17.97 $2.36
Average True Range (ATR) 0.88 0.13
MACD 0.05 0.03
Stochastic Oscillator 80.29 70.59

Price Performance

Historical Comparison
MITK
ALLO

About MITK Mitek Systems Inc.

Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It serves more than 7,900 financial services organizations, financial technology (fintech) brands, telecommunications companies, and marketplace brands across the globe. The company's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online, enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).

Share on Social Networks: